COMMUNIQUÉ DE PRESSE publié le 18/06/2025 à 06:25, il y a 1 année 4 mois Formycon AG: Subscription period for 2025/2029 corporate bond has started Formycon AG announces the start of the subscription period for the 2025/2029 corporate bond with a target volume of EUR 50 million, featuring a variable interest rate. Investors can submit subscription offers until June 27, 2025 Growth Strategy Formycon AG Interest Rate Corporate Bond Subscription Period
COMMUNIQUÉ DE PRESSE publié le 18/06/2025 à 06:14, il y a 1 année 4 mois EQS-Adhoc: Airbus to present new dividend policy and reaffirm cash conversion target during business update on 18 June 2025 Airbus SE to present new dividend policy and reaffirm cash conversion target during business update on June 18, 2025. Strengthening commitment to increasing shareholder returns Business Update Dividend Policy Airbus SE Shareholder Returns Cash Conversion Target
COMMUNIQUÉ DE PRESSE publié le 18/06/2025 à 05:58, il y a 1 année 4 mois Lobe Sciences Moves Forward with Development of Conjugated Psilocin(TM) Following April 14 Agreement to Spin Out Compound to Cynaptec Pharmaceuticals Lobe Sciences Ltd. advances Conjugated Psilocin™ research for chronic cluster headaches and addiction via $6M investment in Cynaptec Pharmaceuticals, with option for additional $20M Clinical Trials Investment Cynaptec Pharmaceuticals Lobe Sciences Ltd. Conjugated Psilocin™
COMMUNIQUÉ DE PRESSE publié le 17/06/2025 à 23:00, il y a 1 année 4 mois New to The Street Signs Backstage ($ BKS) to 12-Part Media Series Covering Music, Sports, and Tokenized Real-World Assets in Entertainment New to The Street announces exclusive media series with Backstage (NASDAQ:BKS) for mainstream adoption of tokenized entertainment. Campaign includes TV, billboards, and editorial support New To The Street Media Series Backstage Tokenized Entertainment Mainstream Adoption
COMMUNIQUÉ DE PRESSE publié le 17/06/2025 à 23:00, il y a 1 année 4 mois Medicure Announces Closing of Purchase Agreement for The Acquisition of West Olympia Pharmacy Medicure Inc. announces acquisition of West Olympia Pharmacy Inc., further boosting direct-to-consumer pharmacy business and sales of ZYPITAMAG(R) and BRENZAVVY(R) Acquisition Medicure Inc. Pharmacy Business ZYPITAMAG(R) BRENZAVVY(R)
COMMUNIQUÉ DE PRESSE publié le 17/06/2025 à 22:50, il y a 1 année 4 mois EQS-Adhoc: Verve Group SE: Verve successfully completes a directed share issue of 12,858,000 new shares raising proceeds of approximately SEK 360 million Verve Group SE successfully completes a directed share issue of 12,858,000 new shares raising proceeds of approximately SEK 360 million. The subscription price is SEK 28.00 per share Market Conditions Subscription Price Verve Group SE Directed Share Issue SEK 360 Million
COMMUNIQUÉ DE PRESSE publié le 17/06/2025 à 22:50, il y a 1 année 4 mois Verve Group SE (Nordic): Verve successfully completes a directed share issue of 12,858,000 new shares raising proceeds of approximately SEK 360 million Verve Group SE completes directed share issue of 12,858,000 new shares, raising SEK 360 million. Key investors include industry experts. Proceeds to fund growth initiatives and strengthen balance sheet Investor Base Share Issue Verve Group SE Directed Share Issue SEK 360 Million
COMMUNIQUÉ DE PRESSE publié le 17/06/2025 à 22:10, il y a 1 année 4 mois Applied DNA Announces Retirement of Chairperson and CEO Dr. James A. Hayward Judy Murrah appointed Chairperson and CEO of Applied DNA Sciences, succeeding Dr. James A. Hayward. Experienced executive aims to lead company's innovative DNA technologies CEO Appointment Applied DNA Sciences DNA Technologies Judy Murrah Dr. James A. Hayward
COMMUNIQUÉ DE PRESSE publié le 17/06/2025 à 20:30, il y a 1 année 4 mois GENFIT: June 17, 2025 Combined Shareholders Meeting Results GENFIT announces approval of all resolutions at June 17, 2025 Combined Shareholders Meeting. Exception: resolution n°28 rejected. Quorum: 27.21% Resolutions Approval Quorum Shareholders Meeting GENFIT
COMMUNIQUÉ DE PRESSE publié le 17/06/2025 à 20:30, il y a 1 année 4 mois GENFIT : Résultats de l’Assemblée Générale Mixte du 17 juin 2025 GENFIT annonce les résultats de son Assemblée Générale Mixte du 17 juin 2025, approuvés avec un quorum de 27,21%, tout en dévoilant sa mission et activités dans le secteur biopharmaceutique Biopharmaceutique Assemblée Générale Mixte Maladies Rares GENFIT Foie
Publié le 13/11/2026 à 11:35, il y a 2 jours 2 heures ENGIE and Google to partner on energy solutions for a potential data center project near Châteauroux, France
Publié le 13/11/2026 à 11:35, il y a 2 jours 2 heures ENGIE et Google s’associent pour développer les solutions énergétiques d’un projet de data center envisagé près de Châteauroux, en France
Publié le 13/11/2026 à 08:00, il y a 2 jours 5 heures Résultats trimestriels au 30 septembre 2026 - ANR par action : 101,54 €, en progression de + 7,8 % sur 9 mois - Capitaux propres consolidés : 772 M€
Publié le 12/11/2026 à 23:12, il y a 2 jours 14 heures Belgrano continues the implementation of its public share buyback offer (OPRA)
Publié le 14/11/2026 à 12:56, il y a 1 jour Gabriel Announces Dismissal of ICSID Annulment Application
Publié le 14/11/2026 à 01:30, il y a 1 jour 12 heures NuRAN Wireless Receives Nasdaq Notification Regarding Minimum Bid Price Deficiency
Publié le 14/11/2026 à 00:40, il y a 1 jour 12 heures BEACN Announces Annual General and Special Meeting Results
Publié le 14/11/2026 à 00:35, il y a 1 jour 13 heures American Hotel Income Properties REIT LP Reports Q3 2026 Results
Publié le 14/11/2026 à 00:00, il y a 1 jour 13 heures SLAM Announces Proposed Extension of Warrant Expiry Dates
Publié le 13/11/2026 à 23:24, il y a 1 jour 14 heures EQS-Adhoc: ASOS PLC: Repurchase of £90m of 2028 Convertible Bonds
Publié le 13/11/2026 à 21:52, il y a 1 jour 15 heures EQS-Adhoc: Airbus reports share buyback transactions 9-13 November 2026
Publié le 13/11/2026 à 19:08, il y a 1 jour 18 heures EQS-Adhoc: CHAPTERS Group AG: Successful Completion of Private Placement of the Capital Increase from Authorized Capital Resolved on November 13, 2026
Publié le 13/11/2026 à 19:00, il y a 1 jour 18 heures Assemblée générale ordinaire des actionnaires le 18 décembre 2026